Effects of different up-dosing regimens for Hymenoptera Venom immunotherapy on serum CTLA-4 and IL-10

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Riccio, Anna Maria ^a   Saverino, Daniele ^b   Pesce, Giampaola ^a   Rogkakou, Anthi ^a   Severino, Maurizio ^c   Bonadonna, Patrizia ^d   Ridolo, Erminia ^e   Mauro, Marina ^f   Canonica, Giorgio Walter ^a   Bagnasco, Marcello ^a   Passalacqua, Giovanni ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c Ospedale San Giovanni di Dio   (Italy)

^d Verona General Hospital   (Italy)

^e UNIVERSITY OF PARMA   (Italy)

^f SANT ANNA HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; HYMENOPTERA VENOM; INTERLEUKIN 10;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DOSE INCREASE; DRUG EFFICACY; FEMALE; HUMAN; HYMENOPTERA VENOM ALLERGY; IMMUNOTHERAPY; INSECT ALLERGY; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; SCHOOL CHILD; TREATMENT DURATION; VENOM IMMUNOTHERAPY;

ADOLESCENT; ADULT; AGED; ANIMALS; CHILD; CTLA-4 ANTIGEN; DESENSITIZATION, IMMUNOLOGIC; FEMALE; HUMANS; HYMENOPTERA; HYPERSENSITIVITY, IMMEDIATE; INSECT BITES AND STINGS; INTERLEUKIN-10; MALE; MIDDLE AGED; VENOMS; YOUNG ADULT;

EID: 84862516955     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0037980     Document Type: Article

References (19)

1. Romagnani S, (2006) Regulation of the T cell response. Clin Exp Allergy 36: 1357-1366.
2. Palomares O, Yaman G, Azkur AK, Akkoc T, Akdis M, et al. (2010) Role of Treg in immune regulation of allergic diseases. Eur J Immunol. 40: 1232-40.
3. Linsley PS, Brady W, Urnes M, Grosmaire LS, Damle K, et al. (1991) CTLA-4 is a second receptor for the B cell activation antigen B7. J Exp Med 174: 561-569.
4. Thompson B, Allison JP, (1997) The emerging role of CTLA-4 as an immune attenuator. Immunity 7: 445-450.
5. Burr JS, Kimzey SL, Randolph DR, Green JM, (2001) CD28 and CTLA-4 coordinately regulate airway inflammatory cell recruitment and T-helper cell differentiation after inhaled allergen. Am J Respir Cell Mol Biol 24: 563-568.
6. Oaks MK, Hallett KM, (2000) A soluble form of CTLA-4 in patients with autoimmune thyroid disease, J Immunol 164: 5015-5018.
7. Saverino D, Brizzolara R, Simone R, Chiappori A, Milintenda Floriani F, et al. (2007) Soluble CTLA-4 in autoimmune thyroid diseases: Relationship with clinical status and possible role in the immune response dysregulation. Clin Immunol 123: 190-198.
8. Wong CK, Lun SWM, Ko FWS, Ip WK, Hui DS, (2005) Increased expression of plasma and cell surface co-stimulatory molecules CTLA-4, CD28 and CD86 in adult patients with allergic asthma. Clin Exp Immunol 141: 122-129.
9. Saverino D, Riccio AM, Rogkakou A, Bagnasco M, Bonadonna P, et al. (2009) Serum cytotoxic T lymphocyte-associated antigen 4 in Hymenoptera venom allergy and its modulation by specific immunotherapy J Allergy Clin Immunol. 123: 258-60.
10. Bilò MB, Rueff F, Mosbech H, Bonifazi F, Oude-Elberinck A, (2005) The EAACI interest group on insect venom hypersensitivity. Diagnosis of Hymenoptera venom allergy. Allergy 60: 1339-49.
11. Waterhouse P, Penninger JM, Timms E, (1995) Lymphoproliferative disorders with early lethality in mice deficient in CTLA-4. Science 270: 985-988.
12. Perez VL, Van Parijs L, Biuckians A, (1997) Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement. Immunity 6: 411-417.
13. Keane-Myers A, Gause WC, Linsley PS, (1997) B7-CD28/CTLA-4 costimulatory pathways are required for the development of T helper cell 2-mediated allergic airway responses to inhaled antigens. J Immunol 158: 2042-2049.
14. Jasek M, Łuszczek W, Obojski A, Winiarska B, Hałubek K, et al. (2006) Distribution of CTLA-4 polymorphisms in allergic asthma. Int Arch Allergy Immunol (141): 223-9.
15. Ip WK, Wong CK, Leung TF, Lam CW, (2006) Plasma concentrations of soluble CTLA-4, CD28, CD80 and CD86 costimulatory molecules reflect disease severity of acute asthma in children. Pediatr Pulmonol. 41: 674-82.
16. Kawayama T, Kinoshita T, Imaoka H, Gauvreau GM, O'Byrne PM, et al. (2008) Effects of inhaled fluticasone propionate on CTLA-4-positive CD4+CD25+ cells in induced sputum in mild asthmatics. Respirology. 13: 1000-1007.
17. Akdis CA, Akdis M, (2011) Mechanisms of allergen specific immunotherapy J Allergy Clin Immunol. 127: 18-27.
18. Dreschler K, Bratke K, Petermann S, Bier A, Thamm P, et al. (2011) Impact of immunotherapy on blood dendritic cells in patients with Hymenoptera venom allergy ImmunotherapyJ Allergy Clin Immunol. 127 (2): 487-494.
19. Bussmann C, Xia J, Allam JP, Maintz L, Bieber T, et al. (2010) Early markers for protective mechanisms during rush venom immunotherapy Allergy. 65(12): 1558-65.